FDA Drugs recall ·

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only… recall

Recall number
D-0027-2026
Date
(initiated October 9, 2025)
Company / brand
Amerisource Health Services LLC
2550 John Glenn Ave Ste A, Columbus, OH, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
27,868 blister packs
Hazard tags
Manufacturing practices (cGMP)
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

Why was it recalled?

CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot #: 1017392, Exp. Date 01/31/2026; 1017415, Exp. Date 12/31/2025.

Distribution

Nationwide within the United States

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0027-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.